|
| 'Chitosan (1) | 1 (2) | 1, 3, 4 - oxadiazoles (1) |
| 1,2,3,4-tetrahydro-9Hpyrido [3,4-b] indole-3-carboxylic acid (1) | 1,3,4-Oxadiazole (1) | 1,3,4-Oxadiazoles (1) |
| 1-butyl-3-methyl imidazolium bromide (1) | 1-butyl-3-methyl imidazolium chloride. (1) | 1-methyl-4-phenyl-1 (1) |
| 12-Dimethylbenz[a]anthracene (1) | 18 β-glycyrrhetic acid (1) | 2 (2) |
| 2, 5-diaza bicyclo [4.3.1] compounds (1) | 2,2-diphenyl-1-picrylhdrazyl (1) | 2-(N-hydroxymethyl amino)-indol-3-yl-propanoic acid (1) |
| 2-aminobenzothiazole (1) | 2-Hydroxypropyl-β-cyclodextrin (1) | 23 factorial design (1) |
| 25(OH)2D (1) | 3 (2) | 3-Methyl-2-benzothiazonium hydrazone hydrochloride (1) |
| 32 factorial design (1) | 3D QSAR (1) | 3D-QSAR (1) |
| 3’ UTR region (1) | 4 - acetamido phenoxy acetyl hydrazide (1) | 4-dihydroxy-4-methoxybenzophenone- 2-O-β-d-glucopyranoside (1) |
| 4-pyridinecarboxylic acid hydrazide (1) | 4-Thiadiazole-2-amine (1) | 5-fluoroindolin-2-one (1) |
| 5-Fluorouracil (1) | 5-HT 3 receptor antagonists (1) | 5-Piperazinedione (1) |
| 6 (1) | 6-Mercaptopurine (1) | 6-Methylmercaptopurine (1) |
| 6-tetrahydropyridine (MPTP) (1) | 7 (1) | 7-Hydroxy warfarin. (1) |
| 8-iso-Prostaglandin F2α (1) | 99mTc-ciprofloxacin (1) | A. nilotica (1) |
| ABC analysis (4) | ABC-VED matrix (4) | Abdominal Pregnancy (1) |
| Abheshaja (1) | Absorbance ratio (1) | Absorption ratio (1) |
| ABTS (1) | Abuse (1) | Academic Stressors scale (1) |
| Accuracy. (1) | Accurate (1) | ACE (2) |
| ACE inhibitor (1) | Aceclofenac (1) | Acetazolamide (1) |
| Acetic acid induced rat colitis (1) | acetic acid induced writhing test (1) | Acetyl cholinesterase estimation (1) |
| Acetyl isoniazid (1) | Acetylation rate (1) | Acetylcholinesterase (1) |
| Acetylcholinesterase inhibitors (1) | ACF (1) | Acid hydrolysis (1) |
| Acid violet 43 (1) | Acid-resistant capsules (1) | Acne (1) |
| Acne vulgaris (1) | Aconitine (1) | Acquired immune deÞ ciency syndrome (1) |
| Acrylamide grafted ghatti gum; Biodegradable; Diclofenac sodium; pH-sensitive hydrogel; Controlled-release. (1) | Actinomycetes (1) | Activator procaspase-3 (1) |
| active pharmaceutical ingredient (1) | Active site (1) | Activities of daily living (ADL) scale (1) |
| Acupuncture (1) | Acute appendicitis (1) | Acute generalized exanthematous pustulosis (1) |
| Acute Inflammation (1) | Acute inß ammation (1) | Acute poisoning (1) |
| Acute ST segment elevation myocardial infarction (1) | Acute toxicity (1) | acyclovir (2) |
| Adenanthera (1) | Adenosine A 2A antagonist (1) | Adherence (5) |
| Adherence. (1) | Adiantum venustum (1) | Adjuvant therapy (1) |
| ADME properties. (1) | ADR (2) | ADR management (1) |
| ADR monitoring centre (AMC). (1) | ADRs (2) | Adsorbent (1) |
| Adverse drug event (1) | adverse drug events (1) | Adverse drug reaction (9) |
| Adverse Drug Reaction (ADR) (1) | Adverse Drug Reaction and Antihypertensive medications. (1) | Adverse drug reaction. (1) |
| Adverse Drug Reactions (8) | Adverse drug reactions (ADRs) (1) | Adverse event following immunization (AEFI) (1) |
| Adverse events (1) | Adverse reaction (1) | Aedes aegypti (2) |
| Aerobic exercise (1) | Aerosil (1) | affective ; assessment ; cognitive ; learning domains ; psychomotor (1) |
| Age (2) | Ageratum conyzoides L (1) | air pollution (1) |
| Airjet (1) | Albendazole (1) | Albino mice (1) |
| Albino wistar rats (1) | Alcohol (2) | alcoholic extract (1) |
| ALDEN (1) | Aldose reductase inhibitors (1) | allantoin (1) |
| Allergic rhinitis (1) | Allergy (4) | Alloxan (1) |
| Alloxan monohydrate (1) | Alocasia indica Schott (1) | Aloe vera (1) |
| Alpha mangostin (1) | Alpha-adrenoceptor (1) | alpha-delta-bungarotoxin-4 (1) |
| Alpinia speciosa (1) | Alprazolam (1) | Alteration of drug cost (1) |
| Altered Mental Status (AMS) (1) | alternative therapy (1) | Alzheimer's disease (1) |
| Alzheimers disease (1) | Alzheimer’s disease (1) | Amaranthus spinosus Linn (1) |
| Amber (1) | Ambroxol hydrochloride (1) | Amides (1) |
| Amikacin Sulfate (1) | Amino acids (1) | amino benzylated Mannich bases (1) |
| amivudine (1) | Amlodipine (2) | Amlodipine besylate (2) |
| Ammonium salts (1) | Amoora cucullata. (1) | amoxicillin (1) |
| Amoxicillin sodium (1) | Anabolic. (1) | Anaemia (1) |
| Analgesia (1) | analgesic (8) | Analgesic effect (1) |
| analgesic- anti-inß ammatory activity (1) | Analgesics (1) | Analysis in capsules (1) |
| Analysis of variance (1) | Anaphylactic shock (1) | Anaphylaxis. (1) |
| and TGF–β (1) | Andragogy (1) | Anemia (1) |
| Anethum graveolens (1) | Angiogenic growth factors (1) | Angiotensin Converting Enzyme Inhibitors (1) |
| Animal model (1) | antepartum (1) | anthelmintic (1) |
| anthelmintic property (1) | Anthocyanin (1) | Anthracyclines (2) |
| Anti aging (1) | Anti hyperglycemic (1) | Anti inflammatory (1) |
| anti-anxiety activity (1) | Anti-asthmatic activity (1) | Anti-Cancer Activity (1) |
| Anti-diabetes mellitus. (1) | Anti-diabetic drugs (1) | Anti-epileptic drugs utilization (1) |
| Anti-HIV (1) | anti-hypertensive agent (1) | Anti-infective (2) |
| Anti-infective agents (1) | anti-inflammation (1) | anti-inflammatory (7) |
| Anti-inflammatory Activities of Total Leaf Extracts of Ficus sycomorus L. (Moraceae) used in Traditional Medicine in the Treatment of Sickle Cell Disease (1) | anti-inflammatory activity (2) | anti-inflammatory activity', (1) |
| anti-inflammatory agent (1) | anti-inß ammatory (3) | Anti-inß ammatory activity (1) |
| Anti-obesity (1) | Anti-oxidant (2) | Anti-parkinsonism activity (1) |
| anti-spasmodic drug (1) | Anti-tumor agent (1) | antiamnesic agents (1) |
| Antianxiety (1) | antibacterial (3) | antibacterial activity (4) |
| Antibacterial drugs (1) | Antibiotic (2) | antibiotic guidelines (1) |
| Antibiotic Resistance (2) | Antibiotics. (1) | Anticancer (4) |
| Anticancer activity (1) | Anticancer drugs (1) | Anticholinergic (1) |
| Anticoagulant (1) | Anticoagulant service (1) | anticonvulsant activity (1) |
| anticonvulsants (1) | Anticovulsant (1) | Antidepressants (1) |
| Antidesma bunius (2) | Antidiabetic (2) | Antidiabetic activity (2) |
| Antidiabetic agents (1) | antiepileptic agents (1) | Antiepileptic Drugs (2) |
| antifungal (1) | antifungal activity (1) | Antigen (1) |
| antigen protein (1) | Antiglycation (1) | Antihistaminic (2) |
| Antihyperglycemic (1) | Antihypertensive (1) | Antihypertensives (1) |
| Antiinflamatory (1) | Antimalarial (2) | Antimicrobial (4) |
| Antimicrobial activities (1) | Antimicrobial activity (6) | Antimicrobial agent (1) |
| Antimicrobial efficacy (1) | Antimicrobial resistance (1) | Antimicrobial resistance; Prescribing practice; Anti-infective agents; Antibacterials; Pharmacoepidemiology. (1) |
| Antimicrobial Stewardship (1) | Antimicrobials (4) | Antimosquito (1) |
| Antimycotic Activity (1) | antinociceptive (1) | Antioxidant (19) |
| Antioxidant ; carotenoid ; humans ; half-life ; status ; absorption . (1) | Antioxidant activity (6) | antioxidant effect (1) |
| Antioxidant properties (1) | Antioxidants (6) | Antipsychotics (1) |
| antipyretic (2) | Antiretroviral drugs (1) | Antiretroviral therapy (2) |
| Antispasmodic (1) | Antithrombotic (2) | Antithyroid drugs (1) |
| Antitubercular (1) | Antitubercular drugs. (1) | antiulcer (1) |
| Antivenom (1) | Antivenom reactions (1) | Antiviral (1) |
| antiviral activity (1) | Antiviral RNA (1) | Anxiety (2) |
| APAP (1) | APC (1) | Apoptosis (2) |
| Application (1) | Application to PK profile studies (1) | applications (1) |
| Appropriateness (1) | Aqueous extract (3) | AR Caps (1) |
| Arabic gum (1) | ARDS (1) | Area above the blood glucose levels-time curve. (1) |
| area of wound healing (1) | Areca nut (1) | Arginase (2) |
| Arginine (1) | Armodafinil (1) | ART (1) |
| Artemia salina (1) | Artemia salina. (1) | Artemisia absinthium (1) |
| Artemisia macrocephala (1) | arterial hypertension (1) | Arteriovenous malformation (AVM) (1) |
| Arthritis (1) | ARV Drugs (1) | Ascorbic acid (3) |
| Asenapine (1) | asian developing nations (1) | Asiaticoside (1) |
| Asparagus racemosus root extract (1) | Aspergillus niger (2) | Aspergillus niger. (1) |
| Aspergillus terreus (1) | Aspirin (1) | Assay (2) |
| Asthma (4) | Asymptomatic neurocognitive impairment (1) | Ataxia (2) |
| ATC/DDD (3) | Atenolol (1) | Atherosclerosis (2) |
| Atherosclerotic Vascular Disease (1) | Atorvastatin (5) | Atorvastatin calcium (1) |
| Atorvastatin. (1) | ATP synthase inhibitor (1) | ATP- sensitive K+channel (1) |
| Atractylis flava Desf (1) | Atrial fibrillation (1) | Atropine (1) |
| Attitude (6) | Attitude and practice (1) | Attitude. (1) |
| Aucubin (1) | Authors (1) | Authorship issues (1) |
| Autism spectrum disorders (1) | Auto antibody (1) | Auto medication (1) |
| Autoimmune disorders (1) | Autoimmunity (1) | Averrhoa bilimbi (1) |
| Avicel (1) | Awareness (2) | Ayurveda (1) |
| Azelaic acid (1) | Azilsartan medoxomil (1) | B cell epitope (1) |
| Bacoside A3 (1) | Bacterial isolates (1) | Bacteriological culture (1) |
| Bacteriostatic (1) | Bamboo betung (1) | Banana (1) |
| Bangladesh (2) | bark (1) | Barleria cristata (1) |
| Barriers (1) | Bauhinia racemosa (1) | Bauhinia variegata (2) |
| Bay-K-8644 (1) | Bayesian confidence propagation neural network (1) | BCG vaccine (1) |
| BCS-IV drug (1) | Beauty Salon Owner (1) | Beck Depression Inventory (1) |
| Beck Depression Inventory(BDI) (1) | Bedaquiline (1) | Belief (1) |
| Benchmarking (1) | Benzimidazole derivative (1) | benzimidazoles (2) |
| Benzodiazepines (1) | Benzothiazole analogues (1) | Berberis integerrima Bunge (1) |
| Beta-lactamic (1) | Bibliometrics (3) | Bioactive Metabolites (1) |
| Bioadhesive (1) | Bioanalytical method (1) | Bioanalytical method development (1) |
| Bioassay (1) | bioavailability (5) | Biodegradable (1) |
| Bioethics (1) | Biohazard (1) | Biologics (1) |
| Biology (1) | Biomedical (1) | Bioprospecting. (1) |
| Biopsy Proven Acute Rejection (1) | Biosafety (1) | Biosafety Engineering Control (1) |
| Biotechnology (1) | Bitter (1) | Black tea extract (1) |
| Bleaching (1) | Bleeding time (1) | Bleomycin (1) |
| Blonanserin (1) | Blood brain barrier (1) | Blood glucose (1) |
| Blood pressure (3) | Body Mass Index (1) | Boerhaavia Diffusa (1) |
| Bone (1) | Book Review (1) | Borg scale (1) |
| botulinum toxin (1) | Box-Behnken (1) | Brahmi vati (1) |
| Brain (1) | brand name drugs (1) | Branded medication (1) |
| Bratton-Marshall reagent (1) | Brazil (1) | Breast cancer (6) |
| Brewer’s yeast (1) | Brief COPE scale (1) | Brief medication questionnaire (1) |
| Brimonidine tartrate (1) | brine shrimp lethality bioassay (1) | Brine-shrimp lethality. (1) |
| Bromelain (1) | Bromeliaceae (1) | Bromocresol purple (1) |
| Bronchial Asthma (1) | Bryonia laciniosa (1) | Buccal (1) |
| Buccal Patches (1) | budget forecasting (1) | Bufadienolide (1) |
| Bullous eruption (1) | bungarotoxin (1) | Bungarus caeruleus (1) |
| Bungur (1) | Buni-berry extract (2) | Buoyant microspheres (1) |
| Burden Of Disease (1) | Business method (1) | Business model (1) |
| Butea monosperma (1) | C934 (1) | Ca2+ channels (1) |
| Cadmium chloride (1) | Caesalpinia decapetala (1) | Caesalpinia pulcherrima (1) |
| Caesalpinia pulcherrima (L.) Sw. stem bark (1) | Calcineurin inhibitor (1) | Calcium (1) |
| Calcium channel blocking (1) | calcium channel blocking activity (1) | Calcium oxalate (1) |
| Calcium silicate (1) | Calendula officinalis (1) | calendula oil (1) |
| Camelia sinensis extract (1) | Camellia sinensis (1) | Camptothecin (1) |
| Cancer (4) | Cancer Chemotherapy (2) | Cancer treatment (1) |
| Candida (1) | Candida albicans (3) | Candida albicans. (1) |
| Capacity (1) | Capsule (1) | capsules (1) |
| carbamazepin (1) | Carbamazepine (2) | carbohydrazide (1) |
| Carbomyl Linkage (1) | carbon tetrachloride (1) | carbonyl compounds (1) |
| Carbopol 940 (1) | Carcinoma. (1) | cardiac arrhythmias (1) |
| Cardiac remodeling (1) | Cardiology (1) | Cardioprotection (1) |
| Cardioprotective (1) | Cardiotoxicity (2) | Cardiovascular disease (1) |
| Cardiovascular drugs (1) | Carnauba wax (1) | carrageenan (2) |
| Caryocar coriaceum (1) | Case report (1) | Casein (1) |
| Casein Phosphopeptide-amorphous calcium Phosphate (1) | Catalase (1) | catalepsy (2) |
| Cation-pi (1) | CationicGuargum (1) | Causality assessment (2) |
| Causality scales (1) | CCKNOW - Crohn’s and Colitis Knowledge assessment questionnaire (1) | CD150 (1) |
| CD244.2 (1) | CD48 (1) | Cefixime (1) |
| Cefotaxime (1) | ceftriaxone and co-amoxiclav (1) | Cefuroxime Axetil (1) |
| cell viability Glycyrrhiza glabra (1) | Cellulase (1) | Cellulite (1) |
| Cellulitis (1) | Cellulose (2) | Cemented (1) |
| Cementless (1) | CEN (1) | Centella asiatica (3) |
| Central composite design (4) | Central post-stroke pain (1) | Cephalexin (2) |
| Cerebrovascular Accident (1) | Cervical dentine hypersensitivity (1) | CFFF (1) |
| chalcone (1) | chalcones (1) | Characterization (4) |
| Chemical stability (1) | Chemiluminescence (1) | Chemomechanical removal (1) |
| Chemometrics (2) | Chemotaxis (1) | Chemotherapy (5) |
| Chewing gum (1) | Child Care (1) | Children (2) |
| Children Dentistry (1) | Chitin (1) | Chitosan (6) |
| Chitosan Acetate. (1) | chitosan microspheres (1) | Chitosan nanoparticle (1) |
| Chitosan-g-HPβCD (1) | Chlamydomonas reinhardtii (1) | Chloramphenicol (1) |
| Chlorhexidine (2) | Chlorohexidine (1) | cholesterol (1) |
| Cholesterol HDL (1) | Cholinesterase inhibitors (1) | Chromotropic acid reagent (1) |
| Chronic Obstructive Pulmonary Disease (COPD) and Elderly Patient. (1) | Chrysophyllum cainito L. leaves (1) | Cicer arietinum (1) |
| Cigarette smoke (1) | Cilostazol (1) | Cinnamaldehyde (1) |
| Cinnamic acid derivatives (1) | Cinnamomum cassia (1) | Ciprofloxacin (1) |
| Citronella (1) | Citrus hystrix (1) | Citrus limon (2) |
| CKD (1) | CKMB. (1) | Claims (1) |
| Clarithromycin (1) | Classification (1) | Clastogenicity (1) |
| Cleistanthin A (2) | cleistanthin B (2) | Cleistanthus Collinus (1) |
| Clinical attachment (1) | Clinical attachment level (1) | Clinical efficacy (1) |
| Clinical equivalence (1) | Clinical manifestation (1) | Clinical Pharmacist (1) |
| Clinical pharmacist care (1) | Clinical pharmacology (1) | Clinical research (1) |
| Clinical trial (1) | Clinical trials (1) | Clinicians (1) |
| clonidine (2) | Clopidogrel (1) | Closed melt (1) |
| Clove (1) | cloxacillin (1) | Cluster analysis (1) |
| CME (1) | Co-crystal (1) | Co-Morbidity (1) |
| Co-morbidity. Correspondence (1) | co-precipitation method (1) | Co-surfactant (1) |
| Cochlopermum tinctorium (1) | coding system (1) | Cognition (2) |
| Cogrinding (1) | Colloidal carriers (1) | Colloidal silicone dioxide (1) |
| Colon targeted delivery (1) | Colon targeted drug delivery. (1) | Colon targeting (1) |
| Colonic delivery (1) | colorimetric assay (1) | Combination tablet (1) |
| Combination Therapy (1) | Combinatorial effect (1) | Comet assay (1) |
| common cold (1) | common cold and cough (1) | Common warts (1) |
| Community Pharmacies (1) | Community pharmacist (1) | Community pharmacy (1) |
| Comorbidity (1) | comparative molecular similarity indices (1) | comparative molecular Þ eld analysis (1) |
| compensation (1) | Complementary and alternative medicine (2) | complementary and alternative medicines (1) |
| Complementary and alternative therapy (1) | complete epithelization (1) | Compliance (1) |
| compound 48/80 (2) | compritol 888 ATO (1) | Computer (1) |
| Computer literacy (1) | computer-aided instructions (1) | Computer-aided learning (1) |
| Computerized screening systems (1) | CoMSIA (1) | Constipation (1) |
| Consumer (1) | Consumer perception (1) | Content validation (1) |
| content validity (1) | continuing education (1) | Contract research (1) |
| Contract research organizations (1) | Controlled release (4) | convolution (1) |
| convulsions (1) | cooperative practice (1) | COPD (2) |
| Coprocessed excipient (1) | Cordia obliqua (1) | Corneal opacities (1) |
| Coronally advanced flap (1) | Correlation (2) | Corticosteroid (2) |
| Corticosteroids (1) | Cosmetic (2) | Cost avoidance (1) |
| Cost of illness (2) | Cost saving (1) | Cost-effectiveness analysis (1) |
| Cost. (1) | Costing Analysis. (1) | Cotton oil (1) |
| cotton pellet (1) | Cough (1) | Cough medicine (1) |
| cough. (1) | Counterfeit Pharmaceutical Products (1) | Cramer’s Matrix method (1) |
| CRC (1) | Cream (1) | creatinine (1) |
| Critical Care Unit (CCU) (1) | Critical Thinking (1) | cromolyn sodium (1) |
| Croscarmellose sodium (CCS) (1) | Crospovidone (1) | Crospovidone (CP) (1) |
| Cross carmellose sodium (1) | cross-linking agents (1) | Crossandra (1) |
| Croton zehntneri (2) | Crystallinity (2) | CTCAE (1) |
| CTEPH (1) | Cucumis metuliferus (1) | Cucumis sativus (1) |
| CUMIN. (1) | Cuminosides (1) | Curcuma longa (1) |
| Curcumin (3) | current indian scenario of drug interactions (1) | curriculum development (1) |
| Cutaneous Adverse Drug Reactions (CADRs) (1) | CXCR4 (1) | Cyclodextrin (1) |
| Cyclooxygenase (1) | cyclophosphamide (1) | Cymbopogon citratus (1) |
| Cynodon dactylon (2) | CYP genes ; South Indian population ; polymorphisms (1) | Cyst (1) |
| Cytochrome P 2C9 (1) | Cytotoxic (1) | Cytotoxic activity. (1) |
| Cytotoxic agents (1) | Cytotoxicity (3) | CZE (1) |
| D&C (1) | D-optimal design (1) | Daily Defined Dose (1) |
| Dapsone (1) | Data mining algorithms (1) | DDX3 (1) |
| Death Receptors (1) | Decision making (1) | Deep vein thrombosis (1) |
| deferasirox (1) | deferiprone (1) | Deficiency (1) |
| Degradation (1) | Degradation studies (1) | Dehydrozingerone (1) |
| Delignification (1) | Delirium (2) | democratic government (1) |
| Dengue high fever (1) | Dental caries (3) | Dental Caries. (1) |
| dental management (1) | Dental prosthesis. (1) | Dental Restoration (1) |
| Dental Students (1) | dentistry. (1) | Deodorants (1) |
| Dependence (1) | Depigmentant (1) | Depok Primary Health Care (1) |
| Deprescribing (1) | Depression (3) | Dermatology life Quality Index (1) |
| Design of experiments. (1) | desirability function (1) | Desirability index. (1) |
| Desmodium gangeticum (1) | Detorsion (1) | Deuterium (1) |
| device safety (1) | dexamethasone (2) | Dexibuprofen (1) |
| Dextrin (1) | Diabetes (5) | diabetes and diabetic vascular complications (1) |
| Diabetes mellitus (11) | diabetes mellitus, (1) | Diabetes Type-II (1) |
| Diabetes, glucose (1) | diabetic dyslipidemia (1) | Diabetic nephropathy (1) |
| Diabetic retinopathy (1) | Diabetic Wound (1) | Diacerein (1) |
| DiaKure (1) | diclofenac (1) | Diclofenac SLN (1) |
| Diclofenac sodium (1) | Dicots (1) | Dicyclomine (1) |
| differential scanning calorimetry (1) | diffuse transmittance (1) | Dillenia indica (2) |
| Dilleniaceae (1) | Diltiazem Efficacy (1) | Diltiazem hydrochloride (2) |
| Dimethylpyrimidin-derivatives (1) | Dip coating (1) | Diplotropis ferruginea (1) |
| direct compression (3) | Direct to consumer advertising (1) | Directly observed treatment short-course (1) |
| Discharge against medical advice (DAMA) (1) | discharge orders (1) | DISCLE (1) |
| Discrepancies (1) | Discriminant analysis (1) | Disease (1) |
| Disease free survival (1) | disintegration (1) | disintegration time (1) |
| Disproportionality Analysis (1) | Dissolution (5) | dissolution enhancement (1) |
| Dissolution rate (1) | Diuretic (1) | Diuretic activity (2) |
| DMAIC (1) | DMH (1) | DNA damage (1) |
| DNA fragmentation (1) | docking (3) | docking. (1) |
| Doctor (1) | Documentation and records (1) | Donepezil hydrochloride (1) |
| Dopamine (1) | Dosage formulation (1) | Dosage regimen (1) |
| Dose-dependent (1) | DOTS plus (1) | Doxorubicin (2) |
| Doxorubicin; FRAP assay (1) | Doxycycline (1) | DPPH Assay (1) |
| DPPH scavenging (1) | DRcaps (1) | DREEM. (1) |
| Dried blood spot. (1) | Dried blood spot; pharmacokinetic; validation; hydrochlorothiazide (1) | droplet size (1) |
| Drug (2) | Drug delivery denture (1) | Drug detailing (1) |
| drug disposal (1) | Drug Hypersensitivity (1) | Drug induced nephrotoxicity (1) |
| Drug Information and Literature Evaluation (1) | drug interaction (2) | Drug interaction (DI) (1) |
| drug interaction management (1) | drug interactions (2) | Drug prescriptions (1) |
| Drug product (1) | Drug Related Problems (4) | Drug related side effects (1) |
| drug release (1) | Drug Resistance (1) | Drug risk ratio (1) |
| Drug safety (2) | Drug Safety. (1) | Drug therapy (1) |
| Drug utilization (3) | drug utilization study (1) | Drug utilization. (1) |
| drug-drug interactions (4) | Drug-related problem (2) | Drug-SLS tablets. (1) |
| Drugedrug interaction (1) | Drugs (2) | drug–drug gliclazide (1) |
| Drug–drug interaction (1) | Dry extract cinnamon (1) | DSPC (1) |
| Dual Therapy (1) | dual-target-directed drugs (1) | Dunaliella salina (1) |
| Dynamic (1) | Dyslipidemias (1) | Dysphagia (1) |
| e-prescribing (1) | E. coli (1) | E.crispa (1) |
| Early-Related Complications (1) | EC50 values (1) | Economic (1) |
| Economic burden (1) | Edaravone (1) | Eddy’s hot plate method. (1) |
| edema (1) | Editorial (24) | Education (2) |
| Educational excellence (1) | efavirenz (2) | Efficacy. (1) |
| EGCG (1) | Egfr (1) | egg albumin microspheres (1) |
| Elderly (1) | Elderly Patients (1) | Electrochemical (1) |
| electrolyte release (1) | electrolytes (1) | Electron beam radiation (1) |
| Electronic prescribing (1) | Electronic prescription (1) | Electroporation (1) |
| Elevated plus maze (1) | elevated plus maze model (1) | Elisa (1) |
| Emblica offi cinalis (1) | Emergency contraception (1) | Emodin (1) |
| Emotional (1) | Emulgel (1) | Emulsification and Solvent Evaporation (1) |
| emulsion solvent diffusion method (1) | emulsion solvent diffusion-evaporation technique (1) | Encholirium spectabile (1) |
| Endocrine disruptor (1) | Endophytes (1) | Endothelial cells (1) |
| endothelial Nitric Oxide Synthase (1) | Endothelial progenitor cells (1) | Endothelium (1) |
| Endothelium. (1) | Enicostemma littorale (1) | Entire plant (1) |
| Entrapment afficiency (1) | entrapment efficiency (2) | Envenoming (1) |
| Environmental Factors (1) | Enzymatic hydrolysis (1) | eosinophil (1) |
| Epigallocatechin Gallate (2) | Epigallocatechin gallate (EGCG) (1) | Epigenetics (1) |
| epilepsy (4) | Epithelial ovarian cancer (1) | erbal drugs (1) |
| erice declaration (1) | Erythema (1) | Erythrina indica (1) |
| Erythrina variegata (1) | erythropoietin (1) | Escherichia coli (1) |
| Escitalopram oxalate (1) | esomeprazole (1) | Essential hypertension (2) |
| Essential medicine (1) | essential medicines (1) | essential oil (4) |
| essential oil composition (1) | Essential principles (1) | Esthetics Dental (1) |
| Estimated Glomerular Filtration Rate (1) | Estrogen receptor alpha (1) | Ethanol (1) |
| Ethanol extract (1) | ethanolic extracts (1) | Ethiopia (2) |
| ethnicity (2) | Ethnomedicine (1) | Ethosomes (1) |
| Ethyl - 4- acetamido phenoxy acetate (1) | Ethyl acetate (1) | Ethyl acetate fraction (1) |
| ethyl cellulose (2) | ethylcellulose (3) | ethylene glycol (2) |
| Eucalyptus (1) | Eucalyptus hybrid (1) | Eucalyptus oil (2) |
| eudragit (1) | Eudragit RL 100 (1) | eudragit S100 (2) |
| Eudragit-L100 (1) | Eudragit® S100 (1) | Eugenol (1) |
| Euphorbia hirta leaves (1) | Eurycoma Longifolia Jack (1) | Ex vivo tissue entrapment (1) |
| ex-vivo performance (1) | Ex-vivo permeation (1) | Ex-vivo study (1) |
| Excision wound model (1) | experiences (1) | Experiential learning (1) |
| Experimental ischemic stroke (1) | Expired medicines (1) | Exports (1) |
| Expression profile (1) | Extract (1) | Extrapyramidal side-effects (1) |
| extrinsic stains (1) | extrusion (1) | Eye lens (1) |
| Ezetimibe (2) | Fabaceae (2) | factorial design (5) |
| Factors associated with medication non-adherence (1) | Falcipain-2 (1) | Family Planning Services (1) |
| Family satisfaction (1) | family therapy (1) | famotidine (2) |
| fast disintegrating tablet (1) | Fast Disintegrating Tablets. (1) | Fast dissolving film (1) |
| Fast dissolving films (1) | Fast dissolving tablets (1) | Fasting serum insulin level (1) |
| Fat (1) | Fatty acid profile (1) | FC reagent (1) |
| FDA AERS Database (1) | FDA Approval (1) | Fenugreek (1) |
| Ferritin (1) | Ferrous sulfate (1) | Fialuridine', (1) |
| Ficus bengalensis (1) | Ficus bengalensis (Moraceae) (1) | Ficus racemosa (1) |
| film (1) | film hydration (1) | First permanent molars (1) |
| Fixed drug eruption (1) | Flavonoid (3) | Flavonoid Compounds (1) |
| Flavonoid fraction (1) | flavonoids (2) | Flavoxate HCl (1) |
| FlK-1 (1) | Floating beads (1) | floating controlled drug-delivery system (1) |
| Floating drug delivery system (1) | floating lag time (1) | fluoroquinoes (1) |
| Fluoxetine (1) | Flupritine maleate (1) | flurbiprofen (1) |
| Flux (1) | folkloric use (1) | Food drug and cosmetic act (1) |
| Forced degradation (3) | Forced degradation studies (1) | forced swim test (1) |
| Formulary (1) | Formulary. (1) | Formulation (2) |
| Formulation and development (1) | Fourier transform infra red spectroscopic (1) | FPG (1) |
| FPGEE (1) | Fraction (1) | Franz Diffusion Cell (3) |
| free radical scavenger (1) | Free radicals. (1) | Freeze-drying (1) |
| Freund’s complete adjuvant (1) | Fructo-Oligosaccharide (FOS) (1) | Frusemide (1) |
| Frusemide-induced complications (1) | FTIR (4) | Fumes (1) |
| furosemide (1) | Galacto-Oligosaccharide (GOS) (1) | Galic Acid (1) |
| gallic acid (2) | Gamma irradiation (1) | Gangrenous (1) |
| Ganoderma lucidum (1) | Gap Junctions; Hypersynchronization; Pentylenetetrazole; Maximal Electroshock (1) | Garcinia daedalanthera extract (1) |
| Garcinia imberti bourd (1) | Garcinia indica (1) | Garcinia latissima (1) |
| gaseous contact (1) | gastric treatment (1) | Gastric ulcer (1) |
| Gastro-retentive drug delivery system (1) | gastroprotection (2) | gastroretentive (1) |
| gastroretentive drug delivery system (1) | Gatot Soebroto hospital. (1) | GC-MS (1) |
| GC-MS analysis (2) | GC-MS. (1) | Gelatin (1) |
| Gelling Capacity. (1) | Gels (1) | gemfibrozil (1) |
| Gender (1) | Gender and HIV. (1) | Gene expression (1) |
| Gene expressions (1) | Gene silencing (1) | General medicine (1) |
| Generic (2) | generic drugs (1) | Generic medicines (2) |
| Generic name. (1) | Generic substitution (1) | Generics (1) |
| Genetic polymorphisms (1) | genetic Signature (1) | Genotype frequency (1) |
| Gentamicin (4) | gentamicin sulfate (2) | Geriatrics (3) |
| GFAP (1) | Gibb’s reagent (1) | Ginger (1) |
| Gingival hyperplasia (1) | Gingival hypertrophy (1) | gingival pocket (1) |
| Gingival recession (1) | Gingival thickness (1) | Gladiolus segetum (1) |
| glibenclamide (4) | gliclazide (2) | Glimepiride (2) |
| glimepride (1) | Glipizide (3) | glitazars (1) |
| Global education (1) | Glomerulonephritis (1) | Glucagon (1) |
| Glucocorticoids (1) | Glucose (1) | glucose tolerance test (1) |
| glutathione (1) | Glycerine (1) | Glycine max (1) |
| Glycosylated hemoglobin (HbA1c) (1) | Glycosylated hemoglobin A1c (1) | Gnetum gnemon (2) |
| Goal orientation (1) | Goldenhar syndrome (1) | good manufacturing practices (1) |
| Gotu kola leaves extract (1) | GPx (1) | Graft Survival (1) |
| Grafting (1) | Gram negative (1) | Gram positive (1) |
| Grape seed extract (1) | Grape seed oil (1) | Grapes seed extract (1) |
| Gravimetry (1) | Grazing angle X-ray diffraction (1) | Green tea (1) |
| Green Tea Leaves Extract (2) | Griseofulvin (1) | GSH (2) |
| guanyl cyclase stimulator (1) | Guest Editorial (1) | Guidelines (1) |
| Gulf cooperation council (1) | Gum and fat fractions (1) | Gum arab (1) |
| Gymnema Sylvestre (2) | GYTS (1) | H+ (1) |
| H-460 (1) | H2 Receptor Antagonist (1) | H2O2 (1) |
| HAART (1) | Haematological (1) | Haemoglobin (1) |
| Haemolytic ratio. (1) | Hair dye. (1) | Hair Growth Activity (1) |
| Hair Tonic (1) | Hajj (1) | haloperidol (1) |
| Hand and Foot Syndrome (1) | hardness (1) | harmacotherapy-based problems (1) |
| Harmonization (2) | Hazardous drugs (1) | HbA1C (2) |
| HBV (1) | HCT: Hydrocholrothiazide. (1) | HDAC4 (1) |
| HDAC7 (1) | head twitch (1) | Health benefits (1) |
| Health care profession (1) | health care professionals (1) | health care students (1) |
| Health care. (1) | Health Hazard (1) | Health informatics (1) |
| Health Information Technology (1) | Health problems (1) | Health Services Accessibility (1) |
| Healthcare (4) | healthcare communication (1) | Healthcare Delivery (1) |
| healthcare expenditure (1) | Healthcare Professionals (1) | healthcare providers (1) |
| Healthy volunteers (1) | heart failure (2) | Hematological parameters (1) |
| hematological toxicity (1) | Hematology (2) | Hematoma (1) |
| Hematopoietic progenitors (1) | hepatic impairment (1) | Hepatitis (1) |
| Hepatitis B (1) | Hepatitis B virus core protein (1) | Hepatocellular (1) |
| Hepatocurative (1) | hepatoprotective (2) | hepatoprotective activity (3) |
| Hepatotoxicity (1) | HER1 (1) | HER2 (1) |
| HER3 (1) | HER4 (1) | Herbal active ingredients (1) |
| Herbal drugs (1) | Herbal medications (1) | Herbal medicine (2) |
| herbal medicines (1) | Herbal therapy (1) | Herbaldb (1) |
| HET-CAM (1) | Heterocyclic compound (1) | Heterotopic Pregnancy (1) |
| Hex (1) | Hexane (1) | Hibiscus cannabinus Linn. (1) |
| Hibiscus rosa. (1) | High fat diet (3) | High Fat Diet Model (1) |
| High impact resin (1) | high performance liquid chromatography (1) | high performance thin layer chromatography (1) |
| High-density lipoprotein cholesterol (1) | High-fat diet (1) | high-performance liquid chromatography (2) |
| High-throughput screening (1) | Higher education (1) | highly active antiretroviral therapy (1) |
| Highly Cited Papers (1) | Himatanthus drasticus (1) | Hip Arthroplasty (1) |
| Hirsutism (2) | Histocompatibility. (1) | Histological studies. (1) |
| Histopathological studies (1) | Histopathology (2) | HIV (1) |
| HIV associated dementia. (1) | HIV-1 RT (1) | HIV-associated neurocognitive disorder (1) |
| HIV/AIDS Patients (1) | HL-60 and K-562 (1) | HLA (1) |
| HMG-CoA Reductase (1) | homology modeling (1) | Honey (1) |
| Honeycomb (1) | Hordeum vulgare (1) | Hordeum vulgare hull (1) |
| Hospital pharmacy (2) | hospitalized children (1) | hospitalized patients (1) |
| Hospitals (1) | host (1) | Host-guest interactions (1) |
| hot plate (1) | HP-ß Cyclodextrin complexes (1) | HPLC (8) |
| HPLC (High Performance Liquid Chromatography) Ornidazole (1) | HPLC method validation (1) | HPLC. (1) |
| HPMC (1) | HPMC capsules (1) | HPMC K100M (1) |
| HPMC K4M (1) | HPTLC (5) | HRQoL (3) |
| HSV-1 (1) | Human breast cancer cells (1) | Human breast cancer MCF -7 cells (1) |
| human immunodeficiency virus (3) | human immunodeÞ ciency virus (1) | Human Papillomavirus (1) |
| Human plasma (2) | human plasma level (1) | Human plasma; Liquid chromatography–tandem mass spectrometry (LC–MS/MS); Method validation; Pharmacokinetics (1) |
| Humanitarian device exemption. (1) | Hydnocarpus Pentandra (1) | Hydralazine hydrochloride (1) |
| Hydroalcoholic (1) | hydrochlorothiazide (1) | Hydrochlorthiazide (1) |
| hydrogel (2) | Hydrogels (1) | hydrogen sulfide (1) |
| hydrogenated castor oil (1) | Hydrophilic drugs (1) | Hydrophillic sealants (1) |
| Hydrophobic sealants (1) | hydroxy propyl methyl cellulose (1) | Hydroxyl radical (1) |
| hydroxypropyl cellulose (1) | hydroxypropyl methyl cellulose (2) | Hydroxypropyl methylcellulose (1) |
| Hydroxypropyl methylcellulose E15 (1) | Hydroxypropyl-β- cyclodextrin (1) | Hydroxypropylmethyl cellulose (1) |
| Hydroxypropylmethylcellulose (1) | Hyperactive orofacial musculature (1) | Hypercholesterolemia (1) |
| Hypercholestremia (1) | Hyperglycemia (1) | Hyperglycemic (3) |
| Hyperglycemic mice (1) | Hyperhomocystienemia (1) | Hyperlipoprotienemia(a) (1) |
| hyperoxaluria (1) | Hypersensitivity (1) | hypertension (5) |
| Hypertension( HTN) (1) | Hypertensive’s (1) | Hyperthyroidism (1) |
| hypertriglyceridemia (2) | Hypertrophy (1) | Hyperzincuria (1) |
| Hyphenated system (1) | hypoglycemic (1) | Hypoglycemic activity (1) |
| hypolipidemic (1) | Hypothyroidism (1) | Hypozincaemia (1) |
| IBD (1) | IBD - Inflammatory Bowel Disease (1) | IC50 (2) |
| ICH (2) | ICH guidelines (2) | ICP22 (US1) gene (1) |
| IL-17 (1) | IL-6 (2) | IL-MAE (2) |
| Illiterate (1) | Iloperidone (1) | image analysis (1) |
| imidazole (1) | Immune response (1) | Immune suppression (1) |
| immunocytochemistry (1) | Immunoinformatics (1) | Immunological response (1) |
| Immunomodulatory (1) | Immunomodulatory effect (1) | In silico (2) |
| in situ gelation (1) | in vitro (4) | In vitro kinetics (1) |
| In vitro penetration lotion (1) | In vitro penetration test (1) | In vitro Penetration Test. (1) |
| In vitro release (1) | In vitro–In vivo (1) | in vivo (1) |
| In vivo kinetics (1) | In-patien (1) | in-vitro dissolution study (1) |
| In-vitro skin permeation (1) | Inclusion complex (1) | inclusion complexes (2) |
| indexed cost (1) | India (7) | India. (1) |
| Indian context (1) | Indian Traditional medicine (1) | Indion 234 (2) |
| Indion resin (1) | indomethacin (2) | Indonesia (1) |
| Indonesian Herbal Database. (1) | Indonesian National Health Insurance (1) | Industry (1) |
| Inequality (1) | infarct size (1) | infective endocarditis (1) |
| infertility (1) | inflammation (3) | inflammatory bowel disease (2) |
| Information need (1) | Information system (1) | Information Technology Officers (1) |
| Information tool (1) | Inhibitor MDM2 (1) | innovation ecosystems (1) |
| inorganic salts. (1) | INR (1) | inß ammation (2) |
| inß ammatory bowel diseases (1) | Insilico anticancer screening (1) | insulin (5) |
| Insulin receptor (1) | Insulin regimen (1) | insulin resistance (1) |
| Insulin resistance. (1) | insulin use in primary care (1) | Insulinophobia (1) |
| Integrase inhibitor (1) | Integrated Courses (1) | integrated economic analysis (1) |
| Intellectual Property l (1) | Intellectual property rights (1) | intelligent tutoring (1) |
| Intensive care unit (1) | Intensive Care Unit (ICU) (1) | Intensive Monitoring (1) |
| interaction (2) | interferon (1) | interleukins (1) |
| International Collaboration (1) | International HIV dementia scale (IHDS) (1) | international organization (1) |
| international organizations (1) | international trade (1) | Internet (1) |
| interpretation (1) | Interventional tool (1) | Intracanal medicament (1) |
| intraocular presuure (1) | Intrauterine Pregnancy (1) | inventory index (1) |
| inventory management (3) | investigators (1) | Invited Article (2) |
| ion pair complex (1) | Ionic gelation (1) | Ionic liquid (3) |
| Ionic liquid- based microwave-assisted extraction (1) | ionic liquid-based microwave-assisted extraction (1) | ionotropic gelation (1) |
| iontophoresis (2) | Iraq (1) | Iridoid glycoside (1) |
| iron chelation therapy (1) | Irvingia gabonensis (1) | isatin (3) |
| ischemia (1) | ischemia-reperfusion injury (1) | Ischemic (1) |
| ischemic heart disease (1) | ISO (1) | isoniazid (2) |
| isonicotinohydrazide (1) | Isoprinosine (1) | Isopropyl myristate (1) |
| isoproterenol (1) | isoxazoline (1) | itopride HCl (1) |
| JNC 8 Guidelines. (1) | Journal (1) | Jurkat (1) |
| K+-ATPase β subunit (1) | K+ATP channel (1) | K-CAPS (1) |
| K562 (1) | Kaffir lime (1) | Kajjali (1) |
| Kalanchoe Pinnata (1) | KAP (1) | KAP study (1) |
| Kappa. (1) | Karachi (2) | Kathakakhadiradi kashyam (1) |
| Kati chakrasana (1) | Kernel powder (1) | Ketoprofen (1) |
| Ketorolac (1) | Ketorolac salt (1) | Key words: 5-FU (1) |
| Key words: Esomeprazole (1) | kidney (2) | kinetic drug release (1) |
| Kinetic Modelling (1) | KMnO4 (1) | kneading method (1) |
| kneading technique (1) | knowledge (9) | Kumar’s score (1) |
| L-arginine (1) | L-Thyroxine (1) | L. acidophilus (1) |
| labeling (1) | Laboratory findings. (1) | Lactobacilli (2) |
| Lactobacillus (1) | Lag period (1) | Lagenaria siceraria (1) |
| Lantana camara (1) | Lantana montevidensis (1) | Larvacidal (1) |
| Laurence-Moon-Bardet-Biedl Syndrome (1) | Lawsone methyl ether (1) | LC/MS/MS (1) |
| LC50 (1) | LCMS/MS (1) | LC–MS/MS (1) |
| LDL-C (1) | Leaf (1) | Learning process (1) |
| leaves (4) | Leftover medicines, (1) | Leg Length (1) |
| Leptin (1) | Letter to Editor (4) | Letter to the Editor (3) |
| Letters to the Editor (6) | Leucaena leucocephala (1) | Leucas lavandulaefolia (1) |
| Levocetirizine (1) | Lichen planus (1) | Licofelone (1) |
| Ligand-based drug design (1) | Lightening (1) | Limb Length (1) |
| Limbs (1) | lime fruit (1) | Linoleic acid (1) |
| lipid matrix (1) | lipid metabolism (2) | lipid microspheres (1) |
| Lipid nanocrystals (1) | Lipid peroxidation (3) | lipid peroxides (1) |
| lipid profile (1) | Lipid profile membrane bound enzymes (1) | lipids (1) |
| lipoic acid (1) | liposome (1) | Lippia (1) |
| lithium toxicity (1) | Live-well™ (1) | liver function (2) |
| Liver necrosis (1) | Liver tonic (1) | Liver Transplantation (1) |
| Local drug delivery (1) | locomotor activity (1) | Low-density lipoprotein cholesterol (1) |
| Lozenges (1) | Luffa echinata (1) | Luminesce (1) |
| Lung (1) | Lung cancer (3) | Lupenoic acid (1) |
| Lupus (1) | Lycatab C (1) | Lympadenopathy (1) |
| lymphadenitis (1) | Lysozyme (1) | M. tuberculosis H37Rv (1) |
| Maceration (1) | Macromicroscopy study (1) | Macrophage cell line (1) |
| Mahkoside A (1) | Major Contributed Organizations (1) | Malaysia (4) |
| Malaysia. (1) | Malaysian. (1) | malondialdehyde (2) |
| Maltodextrin (2) | Mammary carcinoma (1) | Mandibular hypoplasia (1) |
| Mangiferin (1) | Mangosteen Peels (1) | manidipine dihydrochloride (1) |
| Mannich base (1) | Mannich Bases (1) | Marine fungi compounds (1) |
| Mast cell (1) | Maternal Care. (1) | matrix (1) |
| Matrix Tablet (1) | matrix tablets (3) | MCF-7 (1) |
| MDA (2) | MDR-TB (2) | mean age (1) |
| mechanisms (1) | Meclizine HCl (1) | Medical (1) |
| medical costs (1) | Medical device (1) | Medical device recalls (1) |
| medical errors (1) | Medical informatics (1) | Medical Inpatients (1) |
| Medical practitioner (1) | Medical Representative (1) | Medical sales representative (1) |
| Medical students (2) | medication adherence (4) | medication adherence behaviour (1) |
| medication error (2) | Medication errors (1) | Medication non-adherence (1) |
| Medication reconciliation (1) | Medication regimen complexity (1) | medication safety (1) |
| medication-/drug-related problem (MRP/DRP) (1) | Medicinal plants (2) | Medicine (2) |
| Medicine disposal (1) | medicine-use practices (1) | Medicines storage (1) |
| Medicines wastage (1) | Melanesia (1) | Melastoma malabathricum (1) |
| Melinjo (2) | Meloxicam (1) | Memory (1) |
| Memory and learning. (1) | Men (1) | Menstrual cycle (1) |
| Mental health (1) | Mental health services. (1) | Mentha arvensis (1) |
| mesalamine (1) | Metabolic ratio (1) | Metabolic syndrome (1) |
| Metabolism (1) | Metabolite profiling (1) | Metabomics (1) |
| metagenomic (1) | metformin (7) | metformin hydrochloride (1) |
| Methanol (1) | methanolic extract (1) | methocel (1) |
| method development (2) | method validation (3) | Methotrexate (1) |
| methyl orange (1) | methyl-b cyclodextrin (1) | metoprolol tartarate (1) |
| MetS (1) | Mevalonate (1) | Micro emulsion (2) |
| Micro particles. (1) | Micro-emulsion (1) | microbial contamination (1) |
| Microbiological (1) | Microbroth dilution (1) | Microcapsules (1) |
| microcrystalline cellulose (5) | microdilution (1) | Microdosing (1) |
| Microencapsules (1) | microneedles (1) | Micronucleus assay (1) |
| microparticles (1) | microsphere (1) | Microsphere Phytosome (1) |
| microspheres (6) | microtriches (1) | Microwave assisted extraction (1) |
| Microwave-Assisted Extraction (2) | miglitol (1) | Migraine (2) |
| migraine management, (1) | Mild neurocognitive disorder (1) | Milk (1) |
| Milnacipran (1) | Mimosa pudica (1) | Mineral trioxide aggregate (1) |
| minimal inhibitory dose (1) | Minimum Inhibitory Concentration (MIC) (1) | mismatches (1) |
| mitochondria (1) | Mix mode (1) | MMAS-8 - Modified Morisky Adherence Scale-8 (1) |
| Modeling (1) | modern medicine (1) | modified melt dispersion technique (1) |
| Modified Starches (1) | MODY (1) | Mol inspiration (1) |
| Molecular characterization (1) | Molecular docking (10) | molecular docking and anti cancer activity. (1) |
| Molecular Docking. (1) | Molecular Dynamic (1) | Molecular dynamics (3) |
| Molecular Dynamics Simulations (1) | Molecular Imprinted Polymer (1) | Molecular mimicry (1) |
| monoamine oxidase B (1) | Monocots (1) | montelukast (2) |
| montelukast sodium (1) | Montelukast, (1) | moraceae (1) |
| Morbidity (1) | Morin and validation (1) | Moringa oleifera (2) |
| Moringa oleifera. (1) | Morisky medication adherence questionnaire (1) | Mortality (3) |
| Morus alba (1) | Mosquito repellent (1) | Mouth Dissolving Tablets (1) |
| mouth-dissolving film, (1) | MPO activity (1) | MPTP (1) |
| MTT Assay (2) | MTT method (1) | MUC2 (1) |
| MUC6 (1) | Mucoadhesive (1) | Mucoadhesive agent (1) |
| mucoadhesive formulation (1) | Mucoadhesive Oral In situ gel (1) | mucoadhesives (1) |
| mucodhesive (1) | Mulberry (1) | multi granules (1) |
| multidrug resistant pathogens (1) | Multikinase Inhibitor (1) | multiparticulates (1) |
| multiparticulates dosage form (1) | Multiple myeloma (1) | multiple regression (1) |
| multiple regression analysis (1) | Multitargeted drug (1) | Murraya koenigii L.Sprengel S.mutans (1) |
| Mycobacterium tuberculosis. (1) | Mycophenolate mofetil (1) | Mycophenolic acid (1) |
| Myeloperoxidase (1) | myocardial infarction (1) | Myomectomy. (1) |
| Myrica esculenta (1) | Myristicin (1) | N-aminoimidazoles (1) |
| N-napthyl ethylene diamine dihydrochloride (1) | Na+/K+-Atpase (1) | NABP (1) |
| NACO. (1) | Nadi shuddhi pranayama (1) | Naftopidil (1) |
| nano size (1) | Nanoemulsion (1) | Nanoformulation (2) |
| nanoformulations (1) | Nanonization. (1) | Nanopacticle (1) |
| Nanoparticle (1) | Nanoparticles (9) | Nanosuspension (1) |
| Nanosuspension tablets (1) | Nanosuspensions (1) | Naphthoquinone derivative (1) |
| NAPLEX (1) | naproxen (1) | Naranjo (1) |
| Naranjo algorithm (2) | Naranjo algorithm. (1) | Naranjo’s ADR probability scale (1) |
| Narikel Lavan (1) | Narrow therapeutic index drugs (1) | Nasal gel (1) |
| Nateglinide (1) | National Fomulary (1) | National Formulary (2) |
| National Health and Morbidity Surveys (1) | National Public Health Programs (1) | Natural (1) |
| natural compounds (3) | Natural Polymers (1) | natural products (2) |
| NCC-PvPI; Hepatitis B vaccine; ADR/AE; VigiFlow; system organ class (SOC) (1) | Nebivolol (2) | nebivolol hydrochloride (1) |
| Necrosis. (1) | need assessment (1) | Nephroprotective (3) |
| Nephrotic syndrome (1) | Nephrotoxicity (1) | Nerium indicum (1) |
| neuropathy (1) | Neurosurgical (1) | neutropenia (1) |
| nevirapine (1) | new molecule (1) | Newborns (1) |
| Nicorandil (1) | Nicotine (1) | Nicotine dependence (1) |
| Nifedipine. (1) | Nigeria. (1) | nigrostriatal pathway (1) |
| Nil (8) | Nill (18) | niosome (1) |
| Niosomes (1) | Nitric acid (1) | Nitric oxide (3) |
| Nitrogen starvation (1) | NK cell (1) | NMDA (1) |
| NMDA receptors (1) | Nodular skin lesions (1) | Non-linear (1) |
| non-prescription medicine use (1) | Non-steroid anti-inflammatory (1) | Non-steroidal anti-inflammatory drugs (1) |
| Non-surgical endodontic therapy. (1) | nonamers. (1) | noncommunicable disease (1) |
| noncompliance (1) | Nonionic surfactants (1) | nootropic (1) |
| Norfloxacin (1) | Normoglycemic rats (1) | northeast India (1) |
| Nose to brain delivery (1) | Nothopanax scutellarium (1) | Nuclear medicine (1) |
| nuclear pharmacy (1) | Nucleo CMP (1) | Nude mice (1) |
| Nutmeg oil (1) | Nutraceuticals (1) | Nutrient starvation (1) |
| Nutrition (1) | Nystagmus Phenytoin toxicity (1) | O-Phenylene diamine (1) |
| Obesity (2) | Occupational health (1) | Ocimum gratissimum (1) |
| Off-label (1) | offending drugs (1) | Okra Mucilage (1) |
| Olmesartan (1) | olmesartan medoxomil (1) | Omega-6 fatty acid (1) |
| Omeprazole. (1) | Omics (1) | Oncology. (1) |
| ondansetron (3) | ondansetron hydrochloride (1) | OPD – Outpatient Department. (1) |
| open field (1) | Ophthalmic (1) | ophthalmic delivery (1) |
| ophthalmic inserts (1) | Opportunities (1) | Optimal stress (1) |
| optimization (7) | Oral bacteria (1) | Oral cancer (2) |
| oral disintegrating tablets (1) | Oral glucose tolerance (1) | oral glucose tolerance test (3) |
| Oral hypoglycemic drugs (1) | oral insulin (1) | Oral Rehabilitation (1) |
| Organ Toxicities (1) | organic acids (1) | organogel (1) |
| Organophosphate (1) | Origanum vulgare (1) | Original Article (3) |
| Originator. (1) | Orlistat (1) | orodispersible tablet (1) |
| orodispersible tablets (2) | Oscillopsia (1) | Osmotic pump (1) |
| Osteoarthritis (1) | Osteoblast (2) | Osteoclast (1) |
| OTC switch (1) | Otomycosis (2) | Outdoor patients (1) |
| Outpatients (1) | ovalbumin (1) | Ovarian (1) |
| Over-the-counter (1) | Overweight (1) | OVX (1) |
| oxazepinone (1) | oxcarbazepine (1) | Oxidation (1) |
| oxidative damage (1) | oxidative stress (6) | Oxyresveratrol (1) |
| oxytetracycline (1) | P-dimethylaminobenzaldeyde (1) | P-drug. (1) |
| P-drugs (1) | P-glycoprotein (1) | P. dulce (Fabaceae) (1) |
| p53 tumor suppressor gene (1) | Package insert (1) | Paediatric (2) |
| Pain (2) | Pain. (1) | Painkiller (1) |
| pair wise procedures (1) | Pakistan (2) | Pakistan. (4) |
| Paliperidone palmitate (1) | Pancreatitis. (1) | Pantoprazole (1) |
| papain (1) | Papain. (1) | PAR-2 receptor (1) |
| para-diaminobenzaldehyde (1) | paracetamol (2) | Paracetamol. (2) |
| Parkinson’s disease (1) | partial least square (1) | particle size analysis (1) |
| PASS (1) | passive avoidance learning (1) | Patch (1) |
| patents (2) | Pathological response (1) | Patient (2) |
| Patient adherence. (1) | patient counseling (1) | Patient counseling and Patient information leaflet (1) |
| patient education (1) | Patient health questionnaire (PHQ) (1) | Patient satisfaction (1) |
| Patient Survival (1) | patient-physician communication (1) | Patient-safety (1) |
| patients (2) | Patients. (1) | paw edema (1) |
| Paw edema. (1) | Paw volume (1) | PE 18:0/18:0-PEG 2000 (1) |
| Pectin (1) | pedagogy (1) | Pediatric (3) |
| Pediatric cancer (1) | Pediculosis (1) | Pegagan extract (1) |
| PEGylation (1) | Pemphigus vulgaris (1) | Penang (1) |
| penetration (3) | penetration enhancer (1) | penetration pressure (1) |
| penicillamine (1) | Penicillins (1) | pentylenetetrazole (1) |
| PEO (1) | Peperomia pellucida (L) Kunth (1) | Peperomia pellucida (L.) Kunth (3) |
| Peppas and Higuchi’s equations (1) | Peptic Ulcer. (1) | peptide vaccine (1) |
| Peptidoglycan (1) | percentage healing of wound area (1) | perception (3) |
| Periauricular tags. (1) | pericyclic fiber (1) | Periodontal disease (1) |
| periodontal diseases (1) | Periodontal dressing (1) | periodontal pocket (1) |
| Peripheral Neuropathy (1) | Permanent (1) | Permeation (2) |
| Peroxisome proliferator-activated receptorg (PPAR-γ) agonists (1) | Persistent ulcer (1) | Personal care products (2) |
| pH dependent approach (1) | pH independence (1) | pH-sensitive (1) |
| Phaleria marcocarpha (1) | Pharm. D. Integrated (1) | Pharm. D. Post Baccalaureate. (1) |
| pharma counseling (1) | pharmaceutical (1) | pharmaceutical advertisements (1) |
| Pharmaceutical care (2) | pharmaceutical care. (1) | pharmaceutical formulations (1) |
| Pharmaceutical Marketing (1) | Pharmaceutical Services (1) | Pharmaceutical-Care (1) |
| Pharmaceutical-industries (1) | Pharmacist (4) | Pharmacist intervention. (1) |
| pharmacist role in public health (1) | Pharmacists (1) | pharmacists India (1) |
| Pharmacodynamic (2) | Pharmacodynamic activity (1) | pharmacodynamics (2) |
| Pharmacogenetics (1) | Pharmacogenomics (1) | pharmacognostic standardization (1) |
| pharmacognostical (1) | pharmacognosy study (1) | Pharmacokinetic (4) |
| Pharmacokinetic interactions. (1) | pharmacokinetics (8) | Pharmacokinetics. (2) |
| Pharmacological properties (1) | Pharmacophore (3) | Pharmacovigilance (14) |
| Pharmacovigilance Programme of India (1) | Pharmacovigilance. (1) | Pharmacovigilante’s (1) |
| pharmacy (5) | pharmacy curriculum (2) | Pharmacy education (1) |
| Pharmacy Enforcement Division (1) | Pharmacy informatics (1) | Pharmacy intervention (1) |
| Pharmacy services (1) | Pharmacy students (1) | Phase diagrams (1) |
| Phase I studies (1) | Phase rule (1) | phase solubility (1) |
| phase solubility profile (1) | Phenobarbitone (1) | Phenolic (1) |
| phenolic compounds (2) | phenolics (1) | phenols (1) |
| Phenothiazine (1) | Phenytoin (2) | Phenytoin cold cream (1) |
| Phenytoin Toxicity (1) | Pheritima posthuma (1) | Phleboliths (1) |
| Phoenix dactylifera (1) | Phosphorylase kinase (1) | Photoprotection. (2) |
| Phthalates (1) | Phyllanthus emblica, (1) | Phylogenetic tree (1) |
| Physical fitness (1) | Physical stability (1) | Physichochemical Characterization (1) |
| Physicians (3) | physicochemical evaluation (1) | physicochemical properties (1) |
| physiochemical descriptor (1) | Physiological role (1) | Phytochemical (2) |
| phytochemical prospection (1) | Phytochemical screening (1) | Phytosome (1) |
| picrotoxin (1) | pictograms (1) | Pilgrims (1) |
| PIM (1) | Pinus merkusii (1) | pioglitazone (1) |
| piperazine citrate (1) | Piperine (2) | Piroxicam (2) |
| Pits and Fissures (1) | Pixel intensity. (1) | Plackett-Burman (1) |
| Plackett-Burman design (1) | plant extracts (1) | plasma (3) |
| Plasma concentration (1) | plasma concentrations (1) | Plasma creatinine (1) |
| Plasma insulin (1) | Plasma urea (1) | plasma-brain correlation (1) |
| Plasma. (1) | Plasmodium falciparum 3D7 (1) | Plasmodium falciparum. (1) |
| Platelet aggregation. (1) | Platelet rich fibrin membrane. (1) | Pleiotropic effects (1) |
| PLGA (1) | PLSR (1) | Pluronic F 127 (1) |
| PM6 (1) | PM7 (1) | Pneumonia (1) |
| Poison (2) | Poisoning pattern (1) | Polarography (1) |
| Poloxamer 188 (1) | Poloxamer 407 (2) | Poloxamer 407. (1) |
| poly (lactic-co-glycolic acid) (1) | Poly herbal (1) | poly(ε-caprolactone) (1) |
| polycaprolactone (1) | Polycystic Ovary Syndrome (1) | Polyelectrolyte complex (PEC) (1) |
| PolyElectrolytecomplex (1) | Polyethylene glycol (1) | Polyherbal (1) |
| polyherbal formulation (3) | Polymeric nanoparticles (2) | polypharmacy (6) |
| polypharmacy in diabetes mellitus. (1) | polyphenols (1) | Polysaccharide (1) |
| polyvinyl alcohol (2) | polyvinyl pyrrolidone (1) | Polyvinylpyrrolidone (1) |
| Polyvynil pyrrolidone (1) | Pomalidomide (1) | PON1 mRNA (2) |
| porosity (1) | Port-A Catheter. (1) | Positive and Negative stressors (1) |
| Positive coping strategies. (1) | Posology (1) | Possible mechanisms (1) |
| Posterior reversible encephalopathy syndrome (1) | Potassium (1) | Potassium Channel (1) |
| Potassium chloride (1) | Potassium Nitrate (1) | PPAR agonists (1) |
| PPARγ agonists. (1) | PPBG (1) | pPharmacokinetics (1) |
| PPP model (1) | practice (3) | practices (1) |
| pravastatin (1) | Pre ADMET (1) | pre prandial (1) |
| Pre University students (1) | Pre-authorization (1) | Prebiotic (2) |
| Precipitation (1) | precise (1) | Precision (1) |
| Predictors (1) | Pregabalin (1) | Pregnancy (3) |
| preliminary screening (1) | Premna esculenta (1) | prescriber (1) |
| Prescribing (1) | Prescribing errors (1) | Prescribing pattern. (1) |
| Prescription (3) | Prescription error. (1) | prescription monitoring (1) |
| prescription only medicines (1) | Prescription pattern (1) | Prescription review (1) |
| pressure dependent approach (1) | Prevalence (3) | Primary health care (2) |
| Primary Health Care. (1) | Principal component analysis (1) | principal component regression (1) |
| Pristane (1) | Private Medical College (1) | PRO (1) |
| Probable (1) | Probiotic (1) | Probiotics (1) |
| Problem-based learning (1) | process capability (1) | Process parameters. (1) |
| Products with Antimicrobial Action. (1) | progesterone (1) | Proniosomal gel (1) |
| propolis (1) | Proportional reporting ratio (1) | propranol hydrochloride (1) |
| Propranolol hydrochloride (1) | Prospective Study (2) | prostaglandins (1) |
| Prosthesis Coloring (1) | Proteasome activity (1) | protein proÞ le (1) |
| proteolytic enzymes (1) | Proton adduct (1) | Proton Pump Inhibitor (2) |
| Proton-pump Inhibitors (1) | Protransfersome (1) | Prteomics (1) |
| Pseudo ternary phase diagrams (1) | Pseudomonas aeruginosa (1) | Psidium Guajava (1) |
| Psychological mindedness (1) | Psychomotor (1) | Psychosis (2) |
| Psychotropic drugs (1) | Psychotropics (1) | Pterocarpus indicus (1) |
| Pterocarpus indicus Willd (1) | Public behavior (1) | Public health hospital (1) |
| Public hospital (1) | Publication (1) | Publications (2) |
| Pulmonary Fibrosis (1) | pulmonary hypertension (1) | Pulmonary toxicity (1) |
| Punica granatum (1) | pyrazine (1) | pyrazoline (1) |
| pyrazolines (1) | Pyrimidine (1) | Q1F (1) |
| QOL (1) | QSAR (2) | qualitative (1) |
| Qualitative analysis (1) | qualitative study (1) | Quality (1) |
| quality assurance (1) | Quality Control (1) | Quality Indicators (1) |
| quality of internet information (1) | quality of life (4) | quantitative structure-activity relationship (1) |
| Quercetin (2) | quinazolin-4(3H)one (1) | quinazolinone (1) |
| Quinazolinone. (1) | quinoline derivatives (1) | R2 values (1) |
| Rabbits. (1) | radical scavenger (1) | radicals (1) |
| radiopharmaceuticals (1) | radiopharmacy (1) | Radioprotective (1) |
| Raillietina echinobothrida (1) | raloxifene hydrochloride (1) | Raman spectroscopy (2) |
| ramipril (2) | ranitidine (1) | Ranitidine hydrochloride (2) |
| Ranitidine’. (1) | ranolazine (1) | Ransmission electron microscopy (1) |
| Rapid disintegration (1) | Rasagiline mesylate (1) | Rat (1) |
| ratio test procedures (1) | Rational pharmacotherapy. (1) | Rational prescribing (1) |
| Rational use of medicine (1) | rational use of medicines (1) | rats (1) |
| Rattus novergicus (1) | re-precipitation (1) | recognized standards (1) |
| recovery studies (1) | Red ginger (1) | Reflective pedagogy paradigm (1) |
| reforms (1) | Regeneration (1) | Regression analysis (1) |
| Regressions statistics (1) | Regulation (1) | Regulations (1) |
| regulatory (2) | Regulatory affairs (1) | regulatory system (1) |
| Relative performance (1) | release kinetics (3) | Release studies. (1) |
| relese kinetics (1) | Removable denture (1) | Renoprotection (1) |
| Renoprotective (1) | repaglinide (2) | reperfusion (1) |
| research (1) | Research Skills. (1) | reserpine (1) |
| Resident doctors (1) | Resistance (3) | Resistant starch (1) |
| Resource poor setting (1) | Respiratory tract (1) | Response Surface Methodology (1) |
| Response surface methodology. (1) | Response to antiretroviral therapy (1) | Resveratrol (2) |
| retail pharmacy (1) | Retention. (1) | Retinopathy (1) |
| retrospective cohort (1) | Retrospective study (2) | reversed-phase chromatography (1) |
| Rhabdomyolysis (1) | Rhaphidophora pinnata (1) | rhizomes (1) |
| Riboflavin (1) | Rice Bran Oil (1) | Rifampicin (1) |
| Ringer’s dextrose (1) | Ringer’s lactate. (1) | Riociguat (1) |
| Risk factor. (1) | Risk factors (2) | Risk Factors. (1) |
| Rituximab (1) | rivastigmine (1) | RNAi (1) |
| RNAi technology (1) | RNTCP (1) | Rodenticides (1) |
| root (1) | Root canal infection (1) | Roots extract (1) |
| Ropinirole (1) | rosuvastatin (2) | rosuvastatin calcium (1) |
| Royal Malaysian Custom Officer (1) | RP-HPLC (6) | RP-HPLC method (1) |
| RP-TLC/Densitometry (1) | RT-qPCR (1) | Rubus fraxinifolius (1) |
| Rubus rosifolius (1) | rupatadine (1) | rutin (1) |
| ß avonoids (2) | S. mutans (1) | S.salivarius (1) |
| S.sanguis (1) | Saccharin (1) | Safe handling guidelines (1) |
| Safety (1) | Sage (1) | Saponin (1) |
| saponins (1) | Sappan wood (1) | Saraschandra (1) |
| Saudi Arabia (1) | Saussurea lappa (1) | scanning electron microscopy (3) |
| Scientific Advertisements (1) | Scientometrics (3) | sclerotherapy (1) |
| Scores. (1) | Se- DeM ODT Expert system (1) | Second-line agents (1) |
| Secondary Level (1) | seizure outcome (1) | Seizures (1) |
| Selected area electron diffraction (1) | Self medication (1) | self-emulsifying drug delivery system (1) |
| Self-Harm (1) | self-medication (5) | self-nanoemulsification (1) |
| Semi-permanent hair dye (1) | senna spectabilis (1) | Sensitive (1) |
| sensory cortical activity. (1) | separation (1) | sepbox (1) |
| Septic shock (1) | Sequences distillation (1) | Sequential optimization (1) |
| Serum (1) | Serum Ferritin (1) | Serum Glutamate-Pyruvate Transaminase (1) |
| Serum Glutamic Oxaloacetic Transaminase (1) | Serum triglyceride (1) | Serum Vitamin D (1) |
| Serum. (1) | sesame oil (1) | severe febrile neutropenia (1) |
| Severe sepsis (1) | Severity (1) | Sexual dysfunction in diabetes (1) |
| Shodhana (1) | Short Communication (3) | short-term memory (1) |
| Sida rhomboidea.Roxb (1) | Side effect (1) | signal detection (1) |
| Signal detection. (1) | Silver nanoparticles (1) | silymarin (1) |
| similarity factor (f2) (2) | simplex lattice (1) | Simplex Lattice Design (2) |
| simultaneous determination (2) | simultaneous extraction (1) | simvastatin (1) |
| simvastatin. (1) | Single nucleotide polymorphism (1) | sintering (1) |
| siRNA (1) | siRNA. (2) | SIRT1 (1) |
| Sirtuin (1) | six sigma (1) | SJS (1) |
| SLAM markers (1) | SLS (1) | Smix. (1) |
| Smoking (1) | smoking cessation. (1) | Smoking. (1) |
| smooth muscle cells (1) | Snake bite (1) | SNEDDS (2) |
| sobatum (1) | Social Media (1) | Social sexual. (1) |
| SOD (1) | Sodium (1) | sodium alginate (1) |
| sodium alginate. (2) | sodium carboxy methyl cellulose (1) | sodium starch glycolate (3) |
| Sodium starch glycolate (SSG) (1) | Solanum nigrum (1) | Solanum trilobatum (1) |
| Solanum viarum (1) | Solanum xanthocarpum, (1) | Solasodine (1) |
| solid dispersion (5) | solid lipid nanoparticles (1) | Solid lipid nanoparticles. (1) |
| Solid Phase Extraction (1) | solubility (5) | Solubility enhancement (1) |
| Solubility. (1) | solvent casting (1) | solvent evaporation (3) |
| Solvent evaporation. (1) | sonication time (1) | sonophoresis (1) |
| Sorafenib (1) | Spacedrepetition. (1) | spasmolytic (1) |
| speciÞ city (1) | Spectrometric (1) | spectrophotometry (2) |
| sperm count (2) | SPF (1) | Spiro compounds (1) |
| Spleen colony assay (1) | sponge implantation assay (1) | sponsors (1) |
| Spontaneous-Reporting. (1) | Sprague Dawley (1) | spray drying (1) |
| SPSS 20. (1) | ST segment elevation (1) | stability (1) |
| stability indicating (1) | stability indicating and validation. (1) | Stability indicating assay (1) |
| Stability indicating assay method (1) | stability indicating method of artemether (1) | stability indicating. (1) |
| Stability of the physical properties (1) | Stability test (1) | stability. (1) |
| stain removal (1) | stakeholders (1) | Standardization (4) |
| Staphylococcus aureus (1) | Starlac (1) | Statin pathway (1) |
| Statins. (1) | Statistical Modeling (1) | Statistical optimization (1) |
| Stelechocarpus burahol (1) | Stem bark extract (1) | Stephania hernandifolia (1) |
| Stereospermum suaveolens (1) | Stereospermum tetragonum (2) | Sterilization Procedures (1) |
| Steroidal alkaloid (1) | Steudnera colocasiifolia (1) | Stevens-Johnson syndrome (1) |
| Stilbene (1) | Stimulantia (1) | Stimuli (1) |
| Stomatitis under prosthesis (1) | Streptococci (1) | Streptococcus mutans (2) |
| Streptokinase (1) | Streptomonospora arabica (1) | Streptomyces (1) |
| Streptozotocin (2) | Streptozotocin (STZ) (1) | streptozotocin-induced diabetes (1) |
| Streptozotocin. (1) | stress (3) | stress studies (2) |
| stroke and cardiac pacemaker. (1) | Stroke prevention (1) | structural descriptor (1) |
| Structured Communication. (1) | Stryphnodendron rotundifolium (1) | students (3) |
| students’ residence (1) | Sub Clinical Hypothyroidism. (1) | Sub-acute Inflammation (1) |
| Subcutaneous fat (1) | sublingual films (1) | substituted acetophenones (1) |
| sucrase (1) | Sudan (1) | Sulfonylurea (2) |
| Sulfonylureas (1) | Sulphorhodamine-B (1) | Sun (1) |
| sun protection factor (2) | Sunlight (1) | Sunscreens. (1) |
| Super disintegrants (1) | superdisintegrants (2) | Superdisintergrants (1) |
| Superoxide Dismutase. (1) | superoxidedismutase (1) | superporous hydrogel composite (1) |
| Supply Chain Management (1) | support staff. (1) | Surface properties (1) |
| surfactant (1) | surfactants (1) | surgical prophylaxis. (1) |
| Surgical. (1) | Survey questionnaire (1) | survey. (1) |
| Survival rate (1) | sustained release (3) | sustained release pellets (1) |
| sustained release. (1) | Sweet orange peel extract (Citrus sinensis) (1) | swelling index (1) |
| swelling studies (1) | Symptoms (1) | Synchronous spectrofluorimetry. (1) |
| Synergism. (1) | Synthesis (2) | Synthesis; 1-allyl-3-benzoylthiourea; COX-2; Analgesic; Lead Compound; (1) |
| Systematic Review. (1) | Systemic steroids. (1) | Systems biotechnology (1) |
| Systolic dysfunction. (1) | T cell epitope (1) | T regs (1) |
| Tab. Pardopa (1) | Tablet Compression (1) | Tacrolimus (1) |
| Tacrolimus Once Daily (1) | Tacrolimus Twice Daily. (1) | Tactile stimulation (1) |
| tail suspension test (1) | Tamarindus indica (1) | Tamilians (1) |
| Tamoxifen (1) | Target delivery (1) | Targeted drug delivery system (1) |
| taste masking (2) | tasteless complex (1) | taxane (1) |
| Taxanes (1) | Taxus baccata (1) | Teaching Hospital (1) |
| Technology (1) | technology-enhanced learning (1) | tegument (1) |
| telmisartan (1) | TEN (1) | Tenofovir disoproxil fumarate (1) |
| Tephrosia purpurea ethanolic seed extract (TpEt). (1) | Terminalia bellirica (1) | Termineliachebula;Plants; Galls;Albendazole; anthelmintic; Drug. (1) |
| Ternary phase diagram (1) | terpenoids (1) | Tertiary Care (1) |
| Tertiary care hospital (2) | testicular damage (1) | testosterone (3) |
| Tetrapreniltoluquinone (1) | thalassemia major (1) | therapeutic angiogenesis (1) |
| therapeutic dose (1) | therapeutic drug monitoring (2) | therapeutic effectiveness (1) |
| Thermoreversible gel (1) | Thixogel (1) | THP-1 (2) |
| Three component system (1) | thrombocytopenia (1) | Thrombolysed subjects (1) |
| Thrombolytic (1) | thrombolytic enzymes (1) | Thyme oleoresin (1) |
| Thyrotoxicosis. (1) | time dependent approach (1) | Time lag (1) |
| Timed release (1) | Tobacco (2) | Tobacco smoking (1) |
| tolbutamide (1) | Tolerance (1) | Tooth brush. (1) |
| Toothpaste. (1) | Topical delivery. (1) | Topical. (1) |
| Total flavonoid (1) | Total flavonoid content (2) | Total phenolic (2) |
| Total phenolic content (1) | total polyphenolic content (1) | total quality management (1) |
| toxicity (5) | Toxicity. (2) | traditional medicine (2) |
| Training of Central sterile and supply department employees (1) | tramadol HCL (1) | Tramadol Hydrochloride (1) |
| Trans-cinnamic acid (1) | Trans-resveratrol (1) | Transcriptomics. (1) |
| transdermal (2) | transfer latency (1) | Transfersome (2) |
| Transfersomes. (1) | Translation (1) | Transmucosal (1) |
| Transmucosal patch (1) | Trauma induced external inflammatory root resorption (1) | Treatment adherence. (1) |
| Treatment outcomes (1) | Treatment success rate (1) | Triacylglycerol. (1) |
| Triamcinalone Acetonide (TRIA) (1) | Trichoderma reesei. (1) | Tricyclic antidepressants (TCA) (1) |
| Triglycerides (1) | Trigonella foenum graecum (1) | Trigonelline (1) |
| Trinidad & Tobago (1) | trinitrobenzene sulfonic acid (1) | Triphala (1) |
| triple distilled water (1) | Triterpenoid. (1) | Triterpenoids (1) |
| Triticum aestivum. (1) | Tropaeolum majus L (1) | tropicamide (1) |
| Troponin-I (1) | Trypsin (1) | TSLP (1) |
| Tuberculosis (4) | Tuberculosis/HIV (1) | Tumor response (1) |
| Tween 80. (1) | Twisted (1) | Tylophora indica (1) |
| Tylophorinidine. (1) | type 2 diabetes (2) | Type 2 diabetes mellitus. (1) |
| type 2 diabetes. (1) | UACR (1) | UCPMP Guidelines (1) |
| ultrasonication-solvent evaporation technique (1) | Ultrasonography (1) | Unani medicine (1) |
| Uncemented (1) | Underutilization of insulin. (1) | Unethical practices. (1) |
| Unique device identification (1) | Universities (1) | Unlicensed. (1) |
| Unnecessary use. (1) | Unused/Unwanted medicines (1) | UPLC/ESI-Q-TOF-MS/MS method Validation (1) |
| Urban area (1) | urea (1) | Urinary Hydrogen Peroxide (1) |
| Urinary tract infection (UTI) (1) | Urine Albumin to Creatinine Ratio (1) | Urine volume (1) |
| urolithiasis (1) | Urtica dioica L (1) | Usefulness. (1) |
| Uterine fibroid (1) | Uterine Perforation. (1) | UV derivative spectrophotometry (1) |
| UV detection (2) | UV Spectrophotometric method (1) | UV spectrophotometry (1) |
| UV-spectrophotometric method (1) | UV-spectrophotometry (2) | UV-Vis spectroscopy (1) |
| Vaccine (1) | Vaccine design (1) | vada (1) |
| vaginal gel (1) | Vaginitis. (1) | Vakrasana (1) |
| validation (16) | Valium (1) | Valproate (1) |
| valsartan (1) | Vanillin (1) | Vanillosmopsis arborea. (1) |
| vascular bundle (1) | vascular permeability (2) | vascular progenitors (1) |
| VED analysis (2) | VED analysis. (2) | VEGFR-2 (1) |
| Venetoclax (1) | Venography and Hemangioma (1) | Venous malformations (VMs) (1) |
| verapamil (3) | Verapamil HCl (1) | Viability (1) |
| Vincristine. (1) | Vinegar (1) | Virtual Screening (1) |
| Viscosity (1) | visible Spectrophotometry (1) | visible spectroscopy (1) |
| Visual analogue scale. (1) | Vitamin D (3) | Vitamin D deficiency (1) |
| Vitamin D. (1) | vitamin E (1) | vitamin E d-α-tocopheryl polyethylene glyco1000 succinate (1) |
| Vitamin. (1) | Vitex agnus Castus (1) | Voltage–gated calcium channels (1) |
| warfarin (2) | Warning signs (1) | Water hyacinth (2) |
| web-based learning (1) | Weibull parameters (1) | West timor (1) |
| Western blot technique (1) | Wet gangrene (1) | wet granulation (1) |
| wetting time (1) | Wheat (1) | White/red patch (1) |
| WHO-QOL BREF questionnaire (1) | WHO-UMC causality assessment system. (1) | Wilson disease (1) |
| Wistar rats. (1) | Withania somnifera. (1) | Withdrawal (1) |
| Women. (1) | Work protection (1) | Wound Healing (1) |
| Wound tissue healing (1) | Wrightia tinctoria (1) | writhing (1) |
| X-ray diffraction (1) | X-ray imaging study. (1) | X-ray powder diffraction (1) |
| xanthan gum (1) | Xanthangum (1) | XDR-TB (1) |
| Xenografts (1) | Xenografts. (1) | XRD (1) |
| Ylang-ylang (1) | Yoga (1) | Yucca gloriosa L. (1) |
| Zea m1 pollen allergen (1) | Zero order release (1) | zero order spectrophotometry (1) |
| zeta potential (1) | zidovudine (1) | Zika virus (1) |
| zinc (1) | Zinc ion (1) | Zingiber officinale (1) |
| Zingiberaceae (1) | zopiclone (1) | [BMIM]PF6 (1) |
| Þ rst-order derivative spectroscopy (1) | Α-amylase (2) | α-glucosidase (1) |
| α-mangostin (1) | β Amyloid1-42 (1) | β-carboline (1) |
| β-carotene production (1) | β-cyclodextrin (3) | γ-oryzanol (1) |
| ε-amino groups (1) | | |
